Tag

Lipoproteins – LDL-P

Cholesterol

#129 – Tom Dayspring, M.D.: The latest insights into cardiovascular disease and lipidology

Atherogenic lipoproteins are really the issue behind clinical atherosclerotic vascular disease. … The data has just become so overwhelming.” —Tom Dayspring

Nutritional biochemistry

#124 – AMA #15: Real-world case studies—metabolic dysregulation, low testosterone, menopause, and more

As a follow up to AMA #14 where Peter explained his framework for analyzing labs, this “Ask Me Anything” (AMA)…

Ketosis

#116 – AMA with Dom D’Agostino, Ph.D., Part I of II: Ketogenic diet, exogenous ketones, and exercise

“If you restore insulin sensitivity, you’re better able to access and burn fat.” — Dom D’Agostino

Diseases

#111 – AMA #14: What lab tests can (and cannot) inform us about our overall objective of longevity

“Metabolic health really matters. It is the common thread that links all of these chronic diseases.” — Peter Attia

Diseases

Measuring cardiovascular disease risk and the importance of apoB

Millions of Americans schedule an annual physical health examination. During their visit, many can expect to get their blood drawn for…

Cholesterol

#21 – Tom Dayspring, M.D., FACP, FNLA – Part II of V: Lipid metrics, lipid measurements, and cholesterol regulation

“If you learn nothing else today, the first thing is, lipids, for the most part, go nowhere in the human body unless they’re a passenger inside a lipoprotein.” –Tom Dayspring

Cholesterol

#19 – Dave Feldman: stress testing the lipid energy model

“I am on a journey of science, not of advocacy: I’m going to be quite a skeptic.”  —Dave Feldman

Cholesterol

Transcript — The Drive — Dave Feldman

Transcript of episode 19 of The Drive with Peter Attia, released October 8, 2018.

Cholesterol

#07 – Deep Dive: Lp(a) — what every doctor, and the 10-20% of the population at risk, needs to know

“Elevated Lp(a) may have conferred a survival advantage for most of human history: a better ability to deal with acute trauma, but possibly at the expense of poor handling of chronic damage. In today’s environment, for many people, that’s not an advantage.” —Peter Attia

Diseases

When does heart disease begin (and what this tells us about prevention)?

Before I get into this post I want to lay a few things out.

Facebook icon Twitter icon Instagram icon Pinterest icon Google+ icon YouTube icon LinkedIn icon Contact icon